Published in Biochem Biophys Res Commun on October 14, 1988
The vitamin d receptor and T cell function. Front Immunol (2013) 1.03
Serum calcium and vitamin D regulate 1,25-dihydroxyvitamin D3 receptor concentration in rat kidney in vivo. Proc Natl Acad Sci U S A (1990) 0.93
Vitamin D and gene networks in human osteoblasts. Front Physiol (2014) 0.89
Cloning and characterization of the mouse vitamin D receptor promoter. Proc Natl Acad Sci U S A (1997) 0.84
Parathyroid hormone decreases renal vitamin D receptor expression in vivo. Proc Natl Acad Sci U S A (2005) 0.79
The paracrine feedback loop between vitamin D₃ (1,25(OH)₂D₃) and PTHrP in prehypertrophic chondrocytes. J Cell Physiol (2014) 0.77
Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med (2000) 5.02
Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med (1995) 2.70
Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med (1998) 2.64
Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. Endocrinology (2000) 2.50
Interactions of persistent environmental organohalogens with the thyroid hormone system: mechanisms and possible consequences for animal and human health. Toxicol Ind Health (1998) 2.24
Association of radiographically evident osteoarthritis with higher bone mineral density and increased bone loss with age. The Rotterdam Study. Arthritis Rheum (1996) 1.72
Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev (2001) 1.69
Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab (1999) 1.67
Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion. Diabetologia (2005) 1.58
Subcellular localization of a rat liver enzyme converting thyroxine into tri-iodothyronine and possible involvement of essential thiol groups. Biochem J (1976) 1.57
A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density. J Bone Miner Res (1996) 1.54
Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med (1992) 1.54
Vertebral deformities and functional impairment in men and women. J Bone Miner Res (1997) 1.53
The association between age and bone mineral density in men and women aged 55 years and over: the Rotterdam Study. Bone Miner (1994) 1.41
In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. J Nucl Med (1991) 1.41
[Cardiovascular effects of hyperthyroidism and their treatment]. Ned Tijdschr Geneeskd (2002) 1.39
Hepatobiliary handling of iodine-125-Tyr3-octreotide and indium-111-DTPA-D-Phe1-octreotide by isolated perfused rat liver. J Nucl Med (1993) 1.38
[A patient with hypocalcemia: an experiment of nature and culture]. Ned Tijdschr Geneeskd (1993) 1.38
Kinetic evidence suggesting two mechanisms for iodothyronine 5'-deiodination in rat cerebral cortex. Proc Natl Acad Sci U S A (1982) 1.37
Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology (1997) 1.34
Prediction of osteoporotic fractures in the general population by a fracture risk score. A 9-year follow-up among middle-aged women. Am J Epidemiol (1990) 1.34
Interference of polychlorinated biphenyls in hepatic and brain thyroid hormone metabolism in fetal and neonatal rats. Toxicol Appl Pharmacol (1993) 1.34
Evidence for two pathways of iodothyronine 5'-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism. J Clin Invest (1983) 1.30
Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin Endocrinol (Oxf) (2000) 1.30
Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Eur J Nucl Med (2001) 1.30
Cerebral cortex responds rapidly to thyroid hormones. Science (1981) 1.29
In vitro inhibition of thyroid hormone sulfation by hydroxylated metabolites of halogenated aromatic hydrocarbons. Chem Res Toxicol (1998) 1.22
Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J Clin Endocrinol Metab (2001) 1.20
Uptake of thyroid hormones in neonatal rat cardiac myocytes. Endocrinology (1996) 1.20
Sequential deiodination of thyroxine in rat liver homogenate. Biochem J (1978) 1.18
Vertebral deformities as predictors of non-vertebral fractures. BMJ (1994) 1.16
Chemically defined neuron groups and their subpopulations in the glomerular layer of the rat main olfactory bulb. Neurosci Res (1995) 1.16
Inhibition of thyroid hormone sulfation by hydroxylated metabolites of polychlorinated biphenyls. Chem Biol Interact (1998) 1.15
Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam Study. Bone (1996) 1.14
Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. Cancer Res (1998) 1.13
Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology (2001) 1.12
Vitamin D receptor genotype is associated with radiographic osteoarthritis at the knee. J Clin Invest (1997) 1.12
Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol (1997) 1.11
Thyroid hormone transporters. Biochem Soc Trans (2005) 1.10
Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Mol Endocrinol (1996) 1.09
Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies. J Clin Endocrinol Metab (2003) 1.09
Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats. J Nucl Med (1995) 1.08
The efficacy and safety of pravastatin, compared to and in combination with bile acid binding resins, in familial hypercholesterolaemia. J Intern Med (1990) 1.08
Ontogeny of iodothyronine deiodinases in human liver. J Clin Endocrinol Metab (1998) 1.08
Mechanism of action of iodothyronine-5'-deiodinase. Biochim Biophys Acta (1979) 1.08
Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size. J Nucl Med (2001) 1.07
Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism. J Clin Endocrinol Metab (1977) 1.06
Beneficial effects of propylthiouracil plus L-thyroxine treatment in a patient with a mutation in MCT8. J Clin Endocrinol Metab (2008) 1.06
Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study. BMJ (1996) 1.05
Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation. Endocrinology (2005) 1.05
Inherited thyroxine excess: a serum abnormality due to an increased affinity for modified albumin. Clin Endocrinol (Oxf) (1981) 1.05
Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy. Eur J Nucl Med (1997) 1.04
Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount. Eur J Nucl Med (1999) 1.04
A tentative review of recent in vitro observations of the enzymatic deiodination of iodothyronines and its possible physiological implications. Mol Cell Endocrinol (1978) 1.04
Kinetics of enzymic reductive deiodination of iodothyronines. Effect of pH. Biochem J (1979) 1.03
Neuropeptide Y innervation and neuropeptide-Y-Y1-receptor-expressing neurons in the paraventricular hypothalamic nucleus of the mouse. Neuroendocrinology (1999) 1.02
Thyroxine and 3,3',5-triiodothyronine are glucuronidated in rat liver by different uridine diphosphate-glucuronyltransferases. Endocrinology (1991) 1.01
Age-associated changes in ultrasound measurements of the calcaneus in men and women: the Rotterdam Study. J Bone Miner Res (1994) 1.01
Identification of thyroid hormone transporters. Biochem Biophys Res Commun (1999) 1.00
Active transport of triiodothyronine (T3) into isolated rat liver cells. FEBS Lett (1978) 1.00
Multiple neurotransmitters in the tuberomammillary nucleus: comparison of rat, mouse, and guinea pig. J Comp Neurol (1992) 0.99
Regulation of thyroid hormone metabolism during fetal development. Mol Cell Endocrinol (1999) 0.98
A two-receptor model for the action of parathyroid hormone on osteoblasts: a role for intracellular free calcium and cAMP. Cell Calcium (1985) 0.98
D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake. J Nucl Med (1997) 0.97
Acute posttranscriptional regulation of cerebrocortical and pituitary iodothyronine 5'-deiodinases by thyroid hormone. Endocrinology (1984) 0.97
The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype. J Bone Miner Res (1997) 0.97
Location of rat liver iodothyronine deiodinating enzymes in the endoplasmic reticulum. Biochim Biophys Acta (1979) 0.97
Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction. J Endocrinol (2006) 0.96
Activation and inactivation of thyroid hormone by type I iodothyronine deiodinase. FEBS Lett (1994) 0.96
Differential expression of sulfotransferase enzymes involved in thyroid hormone metabolism during human placental development. J Clin Endocrinol Metab (2001) 0.95
Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine. J Clin Endocrinol Metab (1977) 0.95
Different pathways of iodothyronine 5'-deiodination in rat cerebral cortex. Biochem Biophys Res Commun (1981) 0.95
The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly. Eur J Clin Invest (1982) 0.94
Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells. Endocrinology (1994) 0.94
Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy. Eur J Nucl Med (1995) 0.94
Hormone secretion in alcohol-induced pseudo-Cushing's syndrome. Differential diagnosis with Cushing disease. JAMA (1979) 0.94
Anti-tumor effects of 1,25-dihydroxyvitamin D3 and vitamin D analogs. Curr Pharm Des (2000) 0.94
Impairment of the selenoenzyme type I iodothyronine deiodinase in C3H/He mice. Endocrinology (1993) 0.94
Original scientific reports. Results of operative treatment of 615 patients with primary hyperparathyroidism. World J Surg (1981) 0.94
Adjacent genes, for COL2A1 and the vitamin D receptor, are associated with separate features of radiographic osteoarthritis of the knee. Arthritis Rheum (2000) 0.94
Bromocriptine in Nelson's syndrome and Cushing's disease. Lancet (1976) 0.94
Synthesis and some properties of sulfate esters and sulfamates of iodothyronines. Endocrinology (1985) 0.94
Interlaboratory variation of vitamin D1) metabolite measurements. J Clin Chem Clin Biochem (1982) 0.94
Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history. Ann N Y Acad Sci (1994) 0.94
The importance of pituitary tumour size in patients with hyperprolactinaemia in relation to hormonal variables and extrasellar extension of tumour. Clin Endocrinol (Oxf) (1980) 0.93
Rapid and selective inner ring deiodination of thyroxine sulfate by rat liver deiodinase. Endocrinology (1985) 0.93
Evidence for 5-hydroxytryptamine, substance P, and thyrotropin-releasing hormone in neurons innervating the phrenic motor nucleus. J Neurosci (1984) 0.93
Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis. Clin Endocrinol (Oxf) (2008) 0.92
Characterization of the uridine diphosphate-glucuronosyltransferase-catalyzing thyroid hormone glucuronidation in man. J Clin Endocrinol Metab (2000) 0.92
Dronerarone acts as a selective inhibitor of 3,5,3'-triiodothyronine binding to thyroid hormone receptor-alpha1: in vitro and in vivo evidence. Endocrinology (2003) 0.92
Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid (2004) 0.91
The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma. J Clin Endocrinol Metab (2011) 0.91
Substrate requirement for inactivation of iodothyronine-5'-deiodinase activity by thiouracil. Biochim Biophys Acta (1981) 0.91